0

IL-5 as a Strong Secretagogue for Human Eosinophils

T Fujisawa, A Terada, J Atsuta, K Iguchi, H Kamiya, M Sakurai

Int Arch Allergy Immunol. 1997 Oct;114 Suppl 1:81-3.

PMID: 9363934

Abstract:

The ability of IL-5 to induce eosinophil degranulation was investigated. Peripheral blood eosinophils from patients with mildly allergic individuals were isolated with CD16- selection method. Eosinophils were then incubated with interleukin-5 (IL-5) (0.1-100 ng/ml) for 1-48 h and EPX in the supernatants were measured with RIA. We found that IL-5 induced significant amount of eosinophil protein X in a concentration-dependent manner at 24 h. Eosinophil viability was about 90% either in the presence or absence of IL-5 at 24 h. Eosinophils stimulated with IL-5 adhered to the plate. Anti-CD18 mAb blocked adhesion and degranulation induced by IL-5. Dexamethasone and TGFbeta significantly inhibited degranulation in a concentration-dependent manner. These results suggest that IL-5 may be a strong secretagogue for eosinophils, that adhesion via beta2 integrin is a requisite for degranulation, and that the anti-inflammatory effect of corticosteroids and TGFbeta may be exerted at least in part, through the inhibition of eosinophil degranulation.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
IAR42413272 IL-5 human IL-5 human Price
qrcode